FDA Inspection 1177649 — Peter Charles Klatsky, M.D., Inc.
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc. on June 22, 2022 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 22, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sunnyvale, CA (United States)